Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I, Randomized Double-Blind, Active Control, Single Dose Escalation Study of P1101 in Healthy Adult Male Subjects

NCT05129644 is registered in ClinicalTrials.gov with PharmaEssentia as lead sponsor.

NCT NCT05129644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05129644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I, Randomized Double-Blind, Active Control, Single Dose Escalation Study of P1101 in Healthy Adult Male Subjects
Lead sponsor
PharmaEssentia
Phase
Phase 1
Overall status
Completed
Start date
November 7, 2009
Completion date
June 26, 2010
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers